DUBLIN–(BUSINESS WIRE)–The “Cell Surface Markers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for Cell Surface Markers estimated at US$615.4 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2026, growing at a CAGR of 8.9% over the analysis period.
Antibodies, one of the segments analyzed in the report, is projected to grow at a 10.7% CAGR to reach US$703.8 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the PCR Arrays segment is readjusted to a revised 6.4% CAGR for the next 7-year period. This segment currently accounts for a 43.8% share of the global Cell Surface Markers market.
The U.S. Market is Estimated at $315.3 Million in 2021, While China is Forecast to Reach $85.5 Million by 2026
The Cell Surface Markers market in the U.S. is estimated at US$315.3 Million in the year 2021. The country currently accounts for a 45.37% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$85.5 Million in the year 2026 trailing a CAGR of 10.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 8.1% respectively over the analysis period.
Within Europe, Germany is forecast to grow at approximately 7.9% CAGR while Rest of European market (as defined in the study) will reach US$93.8 Million by the end of the analysis period. Growth in North America region is attributed to the presence of prominent players, strong focus on R&D and extensive customer base. The regional market growth is augmented by rising use of cell surface markers in personalized medicine and drug discovery. The market growth is also facilitated by rising cases of chronic medical conditions, mainly cancer, and the resulting requirement of effective diagnostic capabilities. Growing healthcare and research expenditure, increased uptake of medical devices, and move towards laboratory automation are the major growth drivers fueling market expansion in developing regions.
Select Competitors (Total 70 Featured) –
- Abbott Laboratories, Inc.
- BD Biosciences
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Grifols, S.A.
- Immucor, Inc.
- Nihon Kohden Corporation
- Siemens Healthineers AG
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Cell Surface Markers: A Prelude
- Researchers Identify Over-Expression of CD8 Marker on Cytotoxic T-Cells in Patients with COVID-19 Infection
- Cell Surface Markers – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Hospitals Eye on CRP as Diagnostic Marker to Distinguish Common Cold from COVID-19
- Robust Demand for Analytical Techniques and Focus on Timely Diagnosis Drive Growth of Global Cell Surface Markers Market
- Research Dominates Cell Surface Markers Market, Clinical Diagnostics to Exhibit Fastest Growth
- Flow Cytometers Lead the Cell Surface Markers Market
- T and B Cells Dominate the Market
- Developed Regions: Major Revenue Contributors
- Developing Regions Drive Future Growth
2. FOCUS ON SELECT PLAYERS
- Recent Market Activity
- Innovations & Advancements
3. MARKET TRENDS & DRIVERS
- High Uptake in Drug Discovery Applications Widens Market Prospects
- Role of Flow Cytometry in Cell Line Development
- Multicolor Flow Cytometry Offers Perfect Option to Understand B-Cell Development
- Hematology Analyzers Gain Traction in Cell Surface Marker Identification
- Growing Hematology Analyzers Market Witnesses Steady Growth
- Key Technology Trends in Hematology Analyzers Market
- Rising Cancer Incidence Worldwide Spurs Demand For Cell Surface Markers
- Select Markers for Cancer Stem Cell Identification
- Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
- Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
- Number of New Cancer Cases and Deaths (in Million) by Region for 2018
- Use of CD Markers in Identification and Classification of Leukocyte Populations
- Most Common CD markers for Flow Cytometry
- Growing Significance of Personalized Medicine: An Opportunity for Cell Surface Markers
- Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
- RNA Sequencing Emerges as Potential Approach to Identify Cell Surface Markers for Enabling Precision Medicine
- Cell Surface Markers Grows Significantly in Stem Cell Research
- Select Cell Surface Markers Used in Stem Cell Identification and Characterization
- Hematopoietic Stem Cell Markers Provide Useful Insights into Hematopoiesis
- Genetically Engineered CAR T-Cells Present Potential Weapon to Eliminate Cancer Stem Cells and Prevent Recurrence of Cancer
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/s98mic
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900